Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40765091	cv-kromos	— (—)	180	192	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Maternal care for known or suspected fetal abnormality and damage

125

134.36

110.49

1.1

1.3

—

Spontaneous abortion

25.03

86.77

1.1

1.0

—

Medical abortion

21.70

75.60

1.1

1.0

—

Procreative management

+∞

66.65

1.0

0.0

—

Pregnancy with abortive outcome

17.79

58.75

1.0

—

Other abnormal products of conception

19.11

58.21

1.0

—

Maternal care for other known or suspected fetal problems

24.52

38.92

1.1

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

8.17

37.17

1.1

—

Abnormal findings on antenatal screening of mother

8.97

32.44

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

19.21

31.63

1.1

1.2

—

Supervision of high-risk pregnancy

+∞

24.54

1.1

0.0

—

Maternal care for known or suspected abnormality of pelvic organs

30.44

24.25

1.0

1.3

—

Postpartum care and examination

+∞

23.28

1.0

0.0

—

Family history of certain disabilities and chronic diseases leading to disablement

20.91

22.57

1.0

1.1

—

Pregnancy examination and test

+∞

21.44

1.0

0.0

—

Haemorrhage in early pregnancy

5.90

20.67

1.1

—

Personal history of other diseases and conditions

7.87

19.02

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

4.63

18.62

1.0

1.1

—

Diabetes mellitus in pregnancy

4.43

16.81

1.0

1.1

—

Premature rupture of membranes

18.53

15.79

1.1

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

114

3.38

15.08

1.0

1.1

—

Antenatal screening

+∞

13.93

1.1

0.0

—

Gestational diabetes (for exclusion)

117

3.24

13.14

1.0

1.1

—

Maternal care for known or suspected malpresentation of fetus

18.75

12.92

1.0

1.3

—

Medical treatment for female infertility

109

3.64

12.67

1.1

1.0

—

Persons encountering health services in circumstances related to reproduction

+∞

12.41

1.1

0.0

—

Prolonged pregnancy

18.05

12.18

1.1

1.2

—

Single delivery by caesarean section

6.86

12.12

1.0

—

False labour

13.66

11.68

1.0

1.2

—

Female infertility

3.60

11.23

1.1

—

Female infertility, cervical, vaginal, other or unspecified origin

3.67

10.97

1.1

—

Pregnancy, childbirth and the puerperium

+∞

10.32

1.1

0.0

—

Contraceptive management

+∞

9.93

1.0

0.0

—

Habitual aborter

16.92

9.89

1.1

1.0

—

Twin gestation

21.73

9.34

1.1

1.2

—

Multiple gestation

21.73

9.34

1.1

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

115

2.74

8.94

1.0

1.1

—

Chromosomal abnormalities, not elsewhere classified

24.23

8.91

1.2

1.0

—

Outcome of delivery

+∞

8.54

1.2

0.0

—

Other obstetric conditions, not elsewhere classified

115

2.69

8.50

1.0

1.1

—

Maternal care for other conditions predominantly related to pregnancy

3.66

7.72

1.1

—

Other complications of labour and delivery, not elsewhere classified

3.47

7.26

1.1

—

Other disorders of amniotic fluid and membranes

13.29

6.74

1.0

1.3

—

Postpartum haemorrhage

3.08

6.69

1.1

—

Supervision of normal pregnancy

+∞

6.61

1.0

0.0

—

Balanced rearrangements and structural markers, not elsewhere classified

+∞

6.29

1.3

0.0

—

Medical observation and evaluation for suspected diseases and conditions

2.82

4.89

1.1

—

Failed induction of labour

4.39

4.43

1.0

1.1

—

Maternal care for cervical incompetence

8.93

4.28

1.0

1.1

—

Single spontaneous delivery

3.77

4.19

1.1

1.0

—

Female infertility, associated with anovulation

3.09

4.08

1.0

1.1

—

Antepartum haemorrhage, not elsewhere classified

10.01

4.01

1.1

—

Complications of labour and delivery

2.24

3.76

1.0

1.1

—

Labour and delivery complicated by fetal stress [distress]

2.31

3.67

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

146

2.08

3.67

1.1

—

Delivery

3.51

3.59

1.1

1.0

—

Multiple delivery

6.17

3.50

1.0

—

Ectopic pregnancy

10.01

3.49

1.2

—

Inflammatory diseases of female pelvic organs

140

1.91

3.35

1.1

—

Atopic dermatitis

138

1.96

3.27

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

148

1.97

3.20

1.1

—

Preterm labour and delivery

2.80

3.08

1.1

—

Other disorders of urethra and urinary system

126

0.28

3.04

1.0

1.1

—

Pneumonia, organism unspecified

137

0.30

3.02

1.0

1.1

—

Benzodiazepine use

168

0.36

2.99

1.0

1.1

—

Caries of enamel

125

1.88

2.99

1.1

—

Nerve, nerve root and plexus disorders

148

0.36

2.90

1.0

1.1

—

Antihypertensive medication - note that there are other indications

162

0.39

2.85

1.0

1.1

—

Noninflammatory disorders of female genital tract

2.02

2.76

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

157

0.38

2.75

1.0

1.1

—

Postpartum hemorraghe, all women as controls

142

1.92

2.70

1.1

—

Retained placenta and membranes, without haemorrhage

3.75

2.67

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

101

0.29

2.67

1.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

101

0.29

2.66

1.0

1.1

—

2.98

2.48

1.0

1.1

—

Persons encountering health services for examination and investigation

2.15

2.35

1.0

1.1

—

Other problems related to primary support group, including family circumstances

2.82

2.32

1.2

1.1

—

Pre-eclampsia or poor fetal growth

139

1.86

2.32

1.0

1.1

—

Examination and observation for other reasons

2.19

2.29

1.0

1.1

—

Other embolism and thrombosis

5.56

2.21

1.0

—

Perineal laceration during delivery

2.07

2.20

1.1

—

Single delivery by forceps and vacuum extractor

2.98

2.15

1.1

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

3.69

2.15

1.0

1.1

—

Other female pelvic inflammatory diseases

2.78

2.13

1.1

—

Statin medication

105

0.38

2.12

1.0

1.1

—

Metabolic disorders

0.36

2.10

1.0

1.1

—

Rotator cuff syndrome

0.00

2.09

0.0

1.0

—

Pain in limb

151

0.42

2.06

1.0

1.1

—

Any event in cancer register

146

0.44

2.02

1.0

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

130

0.33

2.01

1.0

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

2.81

1.99

1.0

1.1

—

4.56

1.94

1.2

1.1

—

Labour and delivery complicated by umbilical cord complications

3.76

1.93

1.0

1.2

—

Other nutritional deficiencies

150

1.70

1.90

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

158

0.45

1.89

1.1

—

Gingivitis and periodontal diseases

1.72

1.88

1.1

1.0

—

Cardiac arrhythmias

119

0.43

1.87

1.1

—

Obesity, other/unspecified

100

1.90

1.85

1.1

—

Dentofacial anomalies [including malocclusion]

148

1.64

1.79

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.96

1.76

1.1

—

Artrosis, including avohilmo

0.41

1.75

1.0

1.1

—

Other coagulation defects

3.34

1.74

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

124

0.44

1.73

1.3

1.1

—

Diseases of oesophagus, stomach and duodenum

145

0.49

1.70

1.0

1.1

—

All pneumoniae

158

0.49

1.67

1.1

—

Influenza and pneumonia

166

0.52

1.65

1.1

—

Inflammatory disease of uterus

2.10

1.65

1.0

1.1

—

Abnormalities of forces of labour

2.80

1.65

1.1

—

Poor fetal growth

1.89

1.65

1.1

—

Disorders of tooth development and eruption

2.47

1.64

1.2

1.1

—

Postpartum haemorrhage due to anatomy

112

1.79

1.64

1.1

—

Diabetes, varying definitions

148

0.51

1.63

1.0

1.1

—

Use of hypnotics and sedatives

130

0.48

1.61

1.1

—

Fall on same level

163

0.56

1.60

1.0

1.1

—

Hard cardiovascular diseases

0.00

1.59

0.0

1.1

—

Persons encountering health services in other circumstances, wide

103

1.60

1.57

1.0

1.1

—

Constipation

0.38

1.53

1.0

1.1

—

Insomnia

143

1.56

1.52

1.0

1.1

—

Excessive vomiting in pregnancy

2.60

1.51

1.0

—

Long labour

1.88

1.51

1.1

—

Finngen Rheumatological endpoints

155

0.55

1.49

1.1

—

Obesity

152

1.61

1.49

1.1

—

Polyarthropathies

100

0.45

1.48

1.1

—

Obesity and other hyperalimentation

152

1.61

1.48

1.1

—

Ovarian cyst

1.74

1.45

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

144

1.56

1.44

1.0

1.1

—

All kidney diseases

162

0.54

1.42

1.0

1.1

—

Postpartum hemorraghe, parous women as controls

150

1.56

1.40

1.1

—

Other soft tissue disorders, not elsewhere classified

151

0.56

1.37

1.1

—

Infections of breast associated with childbirth

2.61

1.37

1.0

1.1

—

Puerperal sepsis

2.61

1.36

1.0

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

1.88

1.34

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

106

0.46

1.34

1.3

1.1

—

Mycoses, including avohilmo

150

1.52

1.34

1.0

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

146

1.54

1.27

1.0

1.1

—

Other bacterial diseases, including avohilmo

129

0.53

1.26

1.0

1.1

—

Benign neoplasm of ovary

2.63

1.21

1.0

1.1

—

Dermatitis and eczema

138

1.46

1.21

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

118

0.54

1.21

1.0

1.1

—

Diabetes mellitus

147

0.59

1.21

1.0

1.1

—

STROKE

0.00

1.19

0.0

1.1

—

Cerebrovascular diseases

0.00

1.19

0.0

1.1

—

Other (not insulin) diabetes medications

119

0.54

1.19

1.0

1.1

—

Other heart diseases, wide

138

0.57

1.19

1.1

—

Adenomyosis (Endometriosis of uterus)

2.30

1.18

1.0

1.1

—

Disorders of synovium and tendon

109

0.47

1.17

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

144

1.48

1.17

1.0

1.1

—

Renal tubulo-interstitial diseases

146

0.55

1.15

1.0

1.1

—

Superficial injury of abdomen, lower back and pelvis

0.00

1.14

0.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

139

1.46

1.12

1.0

1.1

—

Implicit Sepsis, including avohilmo

102

0.49

1.11

1.3

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

123

0.57

1.11

1.1

—

123

0.57

1.11

1.1

—

Type 2 diabetes, definitions combined

115

0.56

1.11

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

115

0.56

1.11

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

140

0.57

1.11

1.1

—

Polycystic ovarian syndrome, broad definition

1.69

1.07

1.0

1.1

—

Lumbar disc prolapse

0.49

1.07

1.2

1.0

—

Other arrhythmias

0.48

1.06

1.2

1.0

—

Genitourinary diseases

1.75

1.06

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.70

1.04

1.0

1.1

—

Leiomyoma of uterus

0.51

1.03

1.0

1.1

—

Sleep disorders

139

1.44

1.02

1.0

1.1

—

Other intervertebral disc disorders

107

0.56

1.02

1.1

—

Other disorders of skin and subcutaneous tissue

0.46

1.02

1.0

1.1

—

Disease of hard tissues of teeth, NOS

1.85

1.01

1.1

—

Intracranial trauma

129

0.58

1.01

1.0

1.1

—

Type 2 diabetes

132

0.61

0.99

1.0

1.1

—

Complications predominantly related to the puerperium

123

1.55

0.99

1.1

—

Propionic acid derivatives

1.89

0.99

1.0

1.2

—

Other diseases of hard tissues of teeth

1.83

0.98

1.1

—

Other noninflammatory disorders of vulva and perineum

0.00

0.97

0.0

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

103

1.44

0.97

1.0

1.1

—

Other viral diseases, not elsewhere classified

0.00

0.97

0.0

1.1

—

Biguanides

114

0.58

0.97

1.0

1.1

—

Leisure time condition

0.00

0.96

0.0

1.1

—

Pregnancy hypertension

147

1.46

0.96

1.0

1.1

—

Explicit Sepsis

1.86

0.96

1.0

1.1

—

Injuries to the head

162

0.66

0.95

1.1

—

Dizziness and giddiness

112

0.56

0.94

1.0

1.1

—

Hallux valgus (acquired)

2.26

0.94

1.2

1.1

—

Spondylopathies

0.46

0.92

1.4

1.1

—

Other specific joint derangements/joint disorders

146

0.64

0.91

1.1

—

Diabetes medication

144

0.65

0.91

1.0

1.1

—

Asthma/COPD (KELA code 203)

156

0.64

0.91

1.1

—

Malaise and fatigue

0.48

0.90

1.0

1.1

—

Care involving use of rehabilitation procedures

0.49

0.90

1.0

1.1

—

Conjunctivitis (acute, non atopic), including avohilmo

125

1.40

0.89

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

102

0.49

0.89

1.2

1.1

—

Open wound of wrist and hand

100

0.48

0.89

1.0

1.1

—

Abnormalities of breathing

140

0.65

0.89

1.1

—

Disorders of gallbladder, biliary tract and pancreas

114

0.60

0.88

1.1

—

Other puerperal infections

1.79

0.87

1.0

1.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

154

1.43

0.87

1.0

1.1

—

Infections of genitourinary tract in pregnancy

2.00

0.87

1.2

1.1

—

Other disorders of ear

0.57

0.86

1.1

—

Venous thromboembolism

1.75

0.83

1.0

1.1

—

Emergency coronary revascularization (for ACS)

0.00

0.82

0.0

1.1

—

Coronary revascularization (ANGIO or CABG)

0.00

0.82

0.0

1.1

—

Percutaneous Coronary Intervention

0.00

0.82

0.0

1.1

—

Major coronary heart disease event

0.00

0.82

0.0

1.1

—

Other diseases of intestines

160

0.70

0.82

1.0

1.1

—

Cerebrovascular diseases (FINNGEN)

0.00

0.81

0.0

1.2

—

Pre-eclampsia

1.61

0.81

1.0

1.1

—

Explicit Sepsis, including avohilmo

1.74

0.81

1.0

1.1

—

Other bacterial diseases

102

0.58

0.80

1.0

1.1

—

Complications of the puerperium, not elsewhere classified

0.00

0.79

0.0

1.1

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.79

0.0

1.1

—

Schizophrenia

0.00

0.79

0.0

1.1

—

Type 1 diabetes, strict definition

0.00

0.78

0.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

109

0.61

0.77

1.1

—

Sequelae of external causes of morbidity and mortality

0.00

0.77

0.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.54

0.77

1.1

—

General symptoms and signs

142

0.71

0.76

1.1

—

Soft tissue disorders

151

0.71

0.76

1.0

1.1

—

DVT of lower extremities and pulmonary embolism

2.16

0.76

1.0

1.1

—

Any reimbursement code in KELA

130

0.69

0.75

1.1

—

Urinary track infection

120

1.34

0.75

1.0

1.1

—

Other sexually transmitted chlamydial diseases

1.84

0.73

1.1

—

Hernia

107

0.62

0.73

1.1

—

Other reaction to severe stress, and adjustment disorders

133

1.43

0.73

1.1

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

2.00

0.72

1.0

1.1

—

Other sexually transmitted chlamydial diseases, including avohilmo

1.67

0.72

1.1

—

Disorders of other endocrine glands

108

0.55

0.72

1.0

1.1

—

Any gastric operation

117

1.33

0.71

1.0

1.1

—

GASTRO-related operations

117

1.33

0.71

1.0

1.1

—

Pre-eclampsia or eclampsia

1.55

0.71

1.0

1.1

—

Dysplasia of cervi uteri

1.54

0.71

1.1

—

Certain infectious and parasitic diseases

117

1.33

0.71

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

126

1.43

0.69

1.1

—

Low back pain

139

0.68

0.69

1.1

—

Cholelithiasis

108

0.63

0.69

1.1

—

Complications of surgical and medical care, not elsewhere classified

145

0.69

0.68

1.1

—

Substance abuse, excluding more controls

100

0.58

0.68

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

150

0.71

0.68

1.0

1.1

—

Autoimmune diseases related-to ILD

160

0.68

0.66

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.49

0.66

1.1

—

Certain infectious and parasitic diseases, including avohilmo

1.41

0.66

1.1

—

Acetic acid derivatives and related substances

1.72

0.65

1.1

1.2

—

Gestational [pregnancy-induced] hypertension

128

1.40

0.64

1.0

1.1

—

Anti-inflammatory and antirheumatic products, non-steroids

1.68

0.64

1.0

1.2

—

ILD medications: azathioprine

1.72

0.64

1.0

1.1

—

Azathioprine

1.72

0.64

1.0

1.1

—

Persons encountering health services for specific procedures and health care

153

0.73

0.62

1.0

1.1

—

Aplastic and other anaemias

1.69

0.62

1.0

1.1

—

Fenamates

1.70

0.62

1.2

—

Stroke, including SAH

0.00

0.62

0.0

1.1

—

Other disorders of veins

1.61

0.61

1.0

1.1

—

Acute tubulo-interstitial nephritis

117

0.65

0.61

1.0

1.1

—

Cystitis

133

1.30

0.61

1.1

—

Liquid cancers, including Hilmo

0.00

0.61

0.0

1.1

—

Haemorrhage from respiratory passages

0.00

0.61

0.0

1.1

—

Hypertrophic disorders of skin

0.00

0.60

0.0

1.1

—

Restless leg syndrome

0.00

0.60

0.0

1.1

—

Sequelae with surgical and medical care as external cause

0.00

0.60

0.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

137

0.65

0.60

1.1

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.57

0.60

1.0

1.1

—

Malignant neoplasm of skin, including Hilmo

0.00

0.60

0.0

1.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.60

0.0

1.1

—

Heterophoria

0.00

0.60

0.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.60

0.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

0.00

0.60

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

139

0.64

0.60

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.59

0.0

1.1

—

Abnormal involuntary movements

0.00

0.59

0.0

1.1

—

Noninfectious colitis NAS

0.00

0.59

0.0

1.1

—

Speech therapy

0.00

0.59

0.0

1.1

—

Other diseases of the digestive system

0.00

0.59

0.0

1.1

—

GI-bleeding

0.00

0.59

0.0

1.1

—

Acne, including avohilmo

132

0.67

0.59

1.0

1.1

—

Cholecystectomy

0.62

0.58

1.1

1.0

—

Periodontitis

119

0.70

0.58

1.0

1.1

—

Diseases of the eye and adnexa

140

0.75

0.58

1.0

1.1

—

MS-disease / Multiple Sclerosis

0.00

0.58

0.0

1.1

—

Benign lipomatous neoplasm

0.00

0.58

0.0

1.1

—

Chronic periodontitis, including avohilmo

119

0.70

0.58

1.0

1.1

—

Tramadol

0.67

0.57

1.1

—

Disorders of thyroid, IBD co-morbidities

0.56

0.57

1.0

1.1

—

Parasetamol

1.32

0.57

1.0

1.1

—

Concussion

125

0.68

0.56

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

0.65

0.56

1.1

—

Impacted maxillary molar

1.62

0.55

1.0

1.1

—

Contact with and exposure to communicable diseases

141

1.34

0.54

1.1

—

Neoplasms

138

1.25

0.54

1.0

1.1

—

Other disorders of breast

1.58

0.54

1.0

1.1

—

Umbilical hernia

1.58

0.54

1.2

1.1

—

Congenital malformations of genital organs

1.57

0.54

1.0

1.1

—

Nonorganic sleeping disorders

1.48

0.53

1.0

—

Implicit Sepsis

0.61

0.53

1.3

1.1

—

Acne vulgaris

1.54

0.53

1.0

1.1

—

Gastro-oesophageal reflux disease

0.59

0.52

1.0

1.1

—

Neurological diseases

143

0.77

0.52

1.0

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.50

0.51

1.0

1.1

—

Codeine or tramadol medication

154

0.78

0.51

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

142

0.70

0.51

1.2

1.1

—

Acute upper respiratory infections

133

1.26

0.50

1.1

—

Iron deficiency anaemia

1.38

0.50

1.0

1.1

—

Exposure to other specified factors

164

0.73

0.50

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

137

1.26

0.50

1.0

1.1

—

Coxibs

1.53

0.49

1.0

1.2

—

Dental pulpitis, including avohilmo

149

1.25

0.48

1.0

1.1

—

Other headache syndromes

109

0.64

0.48

1.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

102

0.63

0.48

1.0

1.1

—

Deforming dorsopathies

1.52

0.48

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.52

0.47

1.0

1.1

—

Intestinal infectious diseases

154

1.25

0.47

1.0

1.1

—

Other joint disorders

146

0.79

0.47

1.1

—

Other heart diseases

0.67

0.47

1.0

1.1

—

Special screening examination for infectious and parasitic diseases

1.49

0.47

1.0

1.1

—

Injuries to the knee and lower leg

157

0.79

0.46

1.1

—

Asthma, unspecified (mode)

0.66

0.46

1.1

—

Temporomandibular joint disorders, including avohilmo

159

1.28

0.46

1.0

1.1

—

Other and unspecified effects of external causes

0.60

0.45

1.4

1.0

—

Caries of dentine, including avohilmo

1.34

0.45

1.1

—

Episodal and paroxysmal disorders

152

0.80

0.44

1.0

1.1

—

Persons with potential health hazards related to communicable diseases

146

1.29

0.44

1.1

—

Cutaneous abscess, furuncle and carbuncle

1.37

0.44

1.0

1.1

—

Fever of other and unknown origin

112

0.70

0.43

1.2

1.0

—

Necrosis of pulp, including avohilmo

138

0.72

0.42

1.2

1.1

—

Other diseases of urinary system

133

1.22

0.42

1.1

—

Other disorders of lacrimal gland

1.40

0.42

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.42

0.0

1.0

—

Transient ischemic attack

0.00

0.42

0.0

1.0

—

Appendectomy

150

1.27

0.42

1.1

—

Other inflammation of eyelid, including avohilmo

139

0.72

0.41

1.0

1.1

—

Other viral diseases, including avohilmo

121

1.31

0.41

1.1

—

Pain in joint

0.71

0.41

1.1

—

Ischaemic Stroke, excluding all haemorrhages

0.00

0.41

0.0

1.0

—

Chronic lower respiratory diseases

156

0.81

0.41

1.1

—

Liquid cancers

0.00

0.41

0.0

1.1

—

Other superficial mycoses, including avohilmo

1.52

0.41

1.0

1.1

—

Presence of other devices

0.00

0.41

0.0

1.1

—

Cerebral cysts

0.00

0.41

0.0

1.1

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.41

0.0

1.1

—

Tonsillectomy and adenotomy

147

1.23

0.41

1.0

1.1

—

Menorrhagia

0.67

0.41

1.1

—

Viral infections of the central nervous system, including avohilmo

0.00

0.41

0.0

1.1

—

Other peripheral vascular diseases

0.00

0.41

0.0

1.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.41

0.0

1.1

—

Other viral hepatitis

0.00

0.41

0.0

1.0

—

Viral hepatitis, IBD co-morbidity

0.00

0.41

0.0

1.1

—

Etanercept

0.00

0.41

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.41

0.0

1.1

—

Viral hepatitis

0.00

0.41

0.0

1.0

—

Other and unspecified injuries of lower leg

0.00

0.41

0.0

1.1

—

Benign neoplasm of bone and articular cartilage

0.00

0.41

0.0

1.0

—

Abnormal results of function studies

0.00

0.41

0.0

1.1

—

Burns and corrosions of external body surface, specified by site

0.00

0.41

0.0

1.0

—

Heartburn

0.00

0.41

0.0

1.2

—

Paralytic ileus and intestinal obstruction

0.00

0.41

0.0

1.1

—

Superficial injury of wrist and hand

1.36

0.41

1.1

—

Other and unspecified rosacea

0.00

0.40

0.0

1.1

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.40

0.0

1.1

—

Open wound of forearm

0.00

0.40

0.0

1.1

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.40

0.0

1.1

—

Bell's palsy

0.00

0.40

0.0

1.1

—

Psoriatic and enteropathic arthropathies

0.00

0.40

0.0

1.1

—

Diplopia

0.00

0.40

0.0

1.1

—

Malignant neoplasm of skin

0.00

0.40

0.0

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.35

0.40

1.1

—

Oral corticosteroids

147

0.80

0.40

1.1

—

LSIL lesion of the cervix uteri

1.33

0.40

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

0.00

0.40

0.0

1.1

—

Stroke, excluding SAH

0.00

0.40

0.0

1.0

—

Schizoaffective disorder

0.00

0.40

0.0

1.0

—

Other and unspecified visual disturbances

0.00

0.40

0.0

1.1

—

Other diseases of liver

0.00

0.40

0.0

1.1

—

Intestinal stricture

0.00

0.40

0.0

1.0

—

Mandibular retrognathia

0.00

0.40

0.0

1.1

—

Fracture of lumbar spine and pelvis

0.00

0.40

0.0

1.1

—

Substance abuse

0.67

0.39

1.0

1.1

—

Infectious mononucleosis

1.43

0.39

1.0

1.1

—

Infectious mononucleosis, including avohilmo

1.43

0.39

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.43

0.39

1.0

1.1

—

Fitting and adjustment of other devices

0.00

0.39

0.0

1.1

—

Hypertrophic scar

0.00

0.39

0.0

1.1

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.39

0.0

1.1

—

Infective dermatitis

0.00

0.39

0.0

1.1

—

Pain associated with micturition

0.00

0.39

0.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

149

0.81

0.39

1.0

1.1

—

Other systemic involvement of connective tissue

1.39

0.38

1.2

1.1

—

Somatoform disorder

1.35

0.37

1.0

1.1

—

Dermatitis

111

0.70

0.37

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

163

0.79

0.36

1.1

—

Disturbances of skin sensation

0.65

0.35

1.0

1.1

—

Other viral diseases

0.65

0.35

1.0

1.1

—

Fracture of lower leg, including ankle

0.64

0.35

1.0

—

Appendicitis, broad definition

145

1.24

0.35

1.1

—

Injuries to the shoulder and upper arm

104

0.74

0.35

1.0

1.1

—

Acute appendicitis, no complications

134

1.26

0.35

1.1

—

Pain in throat and chest

126

0.80

0.35

1.1

—

Diseases of appendix

145

1.23

0.34

1.1

—

Lower back pain or/and sciatica

159

0.82

0.34

1.1

—

Other medical care

1.36

0.34

1.0

1.1

—

Diseases of middle ear and mastoid

155

1.21

0.34

1.0

1.1

—

Codeine

144

0.83

0.33

1.0

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.33

0.33

1.0

1.1

—

Candidiasis, including avohilmo

1.32

0.33

1.0

1.1

—

Acute appendicitis

143

1.23

0.33

1.1

—

Dental caries, including avohilmo

1.30

0.33

1.1

—

Disorders of eyelid, lacrimal system and orbit

122

0.78

0.33

1.1

—

Generalized anxiety disorder

0.68

0.33

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.67

0.33

1.0

1.1

—

ILD medications: immunosuppressive drugs

120

0.75

0.32

1.1

—

Obesity related asthma

1.28

0.32

1.2

1.1

—

Mycoses

1.28

0.32

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

124

1.18

0.31

1.0

1.1

—

Car occupant injured in other and unspecified transport accidents

1.35

0.31

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

157

0.84

0.30

1.0

1.1

—

Fall on same level involving ice and snow

100

0.70

0.30

1.0

1.1

—

Acne

1.29

0.30

1.0

1.1

—

Childhood allergy (age < 16)

1.28

0.29

1.0

—

Asthma and allergy, excluding more controls

1.23

0.29

1.0

1.1

—

Migraine without aura

106

0.75

0.29

1.0

1.1

—

Second line medication for Crohn's disease

110

0.73

0.28

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

153

0.83

0.28

1.1

—

Disorders of breast

133

0.79

0.28

1.0

1.1

—

Headache

142

0.82

0.28

1.0

1.1

—

Autoimmune diseases

136

1.16

0.27

1.0

1.1

—

LSIL lesion of the cervix uteri, vagina or vulva

1.27

0.27

1.1

—

Zoster [herpes zoster], including avohilmo

1.24

0.27

1.0

—

Polyp of the female genital tract

0.69

0.27

1.2

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

130

1.22

0.26

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

100

1.20

0.26

1.0

1.1

—

Sleep disorders (combined)

136

1.15

0.26

1.0

1.1

—

Abnormalities of heart beat

0.70

0.26

1.0

1.1

—

Covid-19 suspected case

0.70

0.26

1.0

1.1

—

Disorders of refraction and accommodation

0.68

0.26

1.2

1.1

—

Dental operations

1.32

0.25

1.0

1.1

—

Panic disorder

0.67

0.25

1.0

1.1

—

Other and unspecified tonsillitis

117

1.21

0.25

1.1

—

Nutritional anaemias

1.24

0.25

1.0

1.1

—

Depression

150

1.16

0.25

1.0

1.1

—

Unspecified fall

1.23

0.25

1.1

1.0

—

Disorders of choroid and retina

1.19

0.25

1.1

—

Disorders of skin appendages

147

0.81

0.24

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.71

0.24

1.0

1.1

—

Gastrointestinal diseases

107

0.84

0.24

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

119

1.21

0.24

1.0

1.1

—

Conjunctivitis

162

0.84

0.23

1.0

1.1

—

Dyspnoea

122

0.83

0.23

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

133

0.86

0.23

1.0

1.1

—

Depression medications

0.82

0.23

1.0

1.1

—

Other systemic involvement of connective tissue (FG)

1.29

0.23

1.2

1.1

—

Inflammatory bowel disease treatment related agents

153

0.87

0.23

1.1

—

Heart failure, strict

0.00

0.22

0.0

1.0

—

All-cause Heart Failure

0.00

0.22

0.0

1.0

—

Heart failure,strict

0.00

0.22

0.0

1.0

—

Basal cell carcinoma

0.00

0.22

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.00

0.22

0.0

1.0

—

Basal cell carcinoma, including Hilmo

0.00

0.22

0.0

1.0

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

1.0

—

Other disorders of patella

1.19

0.21

1.0

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.21

0.0

1.0

—

Mixed disorders of conduct and emotions

0.00

0.21

0.0

1.2

—

Hyperprolactinaemia

0.00

0.21

0.0

1.1

—

6-mercaptopurine

0.00

0.21

0.0

1.1

—

Cluster headache, strict

0.00

0.21

0.0

1.0

—

Toxic effect of ethanol

0.00

0.21

0.0

1.0

—

Cluster headache, wide

0.00

0.21

0.0

1.0

—

D07AA Corticosteroids, weak (group I)

1.19

0.21

1.0

1.1

—

Impetigo

0.00

0.21

0.0

1.1

—

Chronic viral hepatitis

0.00

0.21

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

0.00

0.21

0.0

1.0

—

Contact with heat and hot substances

0.00

0.21

0.0

1.1

—

Dermatitis due to substances taken internally

0.00

0.21

0.0

1.1

—

Pediculosis, acariasis and other infestations

0.00

0.21

0.0

1.1

—

Scleritis and episcleritis

0.00

0.21

0.0

1.0

—

Astigmatism

0.00

0.21

0.0

1.1

—

L04AC Interleukin inhibitors

0.00

0.21

0.0

1.0

—

Viral infections of the central nervous system

0.00

0.21

0.0

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.21

0.0

1.0

—

Sequelae of infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

Inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.0

—

Sequelae of infectious and parasitic diseases, including avohilmo

0.00

0.21

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

0.21

0.0

1.1

—

Malignant neoplasm of endocrine gland, including Hilmo

0.00

0.21

0.0

1.0

—

Nail disorders

0.00

0.21

0.0

1.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.21

0.0

1.0

—

Other psoriatic arthropathies

0.00

0.21

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

0.21

0.0

1.0

—

Psoriatic arthropathies, ICD10

0.00

0.21

0.0

1.0

—

Arthropathic psoriasis

0.00

0.21

0.0

1.0

—

Hydronephrosis

0.00

0.21

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

0.21

0.0

1.1

—

Cholecystitis

0.00

0.21

0.0

1.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

0.21

0.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.21

0.0

1.1

—

Other and unspecified disorders of vitreous body

0.00

0.21

0.0

1.0

—

Dermatophytosis, including avohilmo

123

1.19

0.21

1.0

1.1

—

malignant neoplasm of female genital organs, including Hilmo

0.00

0.21

0.0

1.0

—

Crossbite

0.00

0.21

0.0

1.1

—

Anankastic personality disorder

0.00

0.21

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

0.21

0.0

1.1

—

Asthma mixed form (mode)

0.00

0.21

0.0

1.1

—

Asthma mixed form (mode), excluding more controls

0.00

0.21

0.0

1.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.0

—

Other infectious diseases, including avohilmo

0.00

0.21

0.0

1.0

—

Weight loss

0.00

0.21

0.0

1.2

—

Seborrhoeic dermatitis

0.00

0.21

0.0

1.0

—

Rheumatism, unspecified

0.00

0.21

0.0

1.0

—

Chronic gastritis

0.00

0.21

0.0

1.0

—

Abnormal serum enzyme levels

0.00

0.21

0.0

1.1

—

Urticaria and erythema

1.22

0.21

1.0

1.1

—

L04AX Other immunosuppressants

103

0.78

0.21

1.1

—

Hirsutism in women

0.00

0.21

0.0

1.1

—

Other pulmonary diagnosis

100

1.15

0.21

1.0

1.1

—

Hyperfunction of pituitary gland

0.00

0.21

0.0

1.1

—

Cluster headache, strict, including avohilmo

0.00

0.21

0.0

1.0

—

Cluster headache, wide,, including avohilmo

0.00

0.21

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

0.21

0.0

1.2

—

Trochanteric bursitis

0.00

0.21

0.0

1.1

—

Allergic conjunctivitis

160

0.84

0.21

1.0

1.1

—

Symptoms and signs concerning food and fluid intake

0.00

0.21

0.0

1.2

—

Disorders of conjunctiva

162

0.86

0.20

1.0

1.1

—

Complications of procedures, not elsewhere classified

134

0.84

0.20

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

0.00

0.20

0.0

1.0

—

Urticaria

1.25

0.20

1.0

1.1

—

Hypertrichosis

0.00

0.20

0.0

1.1

—

Agoraphobia

0.00

0.20

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.20

0.0

1.0

—

Lateral epicondylitis

0.00

0.20

0.0

1.1

—

Use of pramipexole

0.00

0.20

0.0

1.0

—

Viral and other specified intestinal infections, including avohilmo

109

0.79

0.20

1.0

1.1

—

Allergic rhinitis

111

0.80

0.20

1.0

1.1

—

Endometriosis of pelvic peritoneum

1.21

0.20

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

157

1.14

0.19

1.0

1.1

—

Sulfasalazine

1.18

0.19

1.3

1.0

—

Asthma, including avohilmo

155

0.89

0.19

1.1

—

Melanocytic naevi

1.23

0.18

1.0

—

Inflammatory bowel disease, strict (require KELA)

1.13

0.18

1.0

1.1

—

Hernia of abdominal wall

1.13

0.18

1.2

1.1

—

Atopic dermatitis, strict definition

125

1.17

0.18

1.0

1.1

—

Injuries to the wrist and hand

158

0.88

0.18

1.0

1.1

—

Asthma and allergy

1.21

0.18

1.0

1.1

—

Anaemias

0.82

0.18

1.0

1.1

—

Migraine

152

0.87

0.17

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

140

1.11

0.17

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

131

1.13

0.17

1.0

1.1

—

Covid-19 confirmed case

1.11

0.17

1.0

—

Myalgia

0.75

0.17

1.0

1.1

—

KRA_PSY_EATING, excluding more controls

0.73

0.17

1.0

1.1

—

Keratitis

0.72

0.16

1.2

1.0

—

Disorders of lacrimal system

1.16

0.16

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

135

1.11

0.16

1.1

—

Other anxiety disorders

147

0.87

0.16

1.0

1.1

—

Osteopathies and chondropathies

1.12

0.16

1.1

1.0

—

Used for control exclusion in common control thyroid runs

132

1.11

0.16

1.0

1.1

—

Pollen allergy

0.77

0.15

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

0.76

0.15

1.0

1.1

—

Neurological diseases, wide definition

0.85

0.15

1.0

1.1

—

Nonorganic sleeping disorders, excluding more controls

1.15

0.15

1.0

1.1

—

Tooth eruption problems

1.14

0.15

1.1

—

Other viral diseases, not elsewhere classified, including avohilmo

1.13

0.15

1.1

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

154

0.87

0.15

1.0

1.1

—

Embedded and impacted teeth

129

1.13

0.14

1.1

—

Herpesviral [herpes simplex] infections, including avohilmo

1.08

0.14

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.16

0.14

1.0

1.1

—

Exposure to unspecified factor

159

0.90

0.14

1.0

1.1

—

Injuries to the elbow and forearm

137

0.88

0.14

1.1

—

Vasomotor and allergic rhinitis

115

0.85

0.14

1.0

1.1

—

Cardiovascular diseases

146

0.91

0.13

1.0

1.1

—

Postpartum haemorrhage due to retained placenta

103

1.17

0.13

1.1

1.0

—

Other and unspecified dermatitis

0.82

0.13

1.0

1.1

—

Injuries to the ankle and foot

163

0.89

0.13

1.1

—

ILD medications

153

0.92

0.12

1.0

1.1

—

Chronic apical periodontitis

153

0.92

0.12

1.0

1.1

—

Obesity due to excess calories

133

1.13

0.12

1.1

—

Diseases of the ear and mastoid process

147

0.92

0.12

1.0

1.1

—

Chronic diseases of tonsils and adenoids

126

1.10

0.11

1.0

1.1

—

ILD differential diagnosis

100

1.10

0.11

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

100

1.10

0.11

1.0

1.1

—

Other dorsopathies, not elsewhere classified

139

1.08

0.11

1.1

—

Selective serotonin reuptake inhibitors

125

0.91

0.11

1.0

1.1

—

Depression or dysthymia

0.87

0.11

1.0

1.1

—

Fracture of forearm

1.15

0.10

1.2

1.1

—

All dysplastic lesions of the cervix uteri

142

1.11

0.10

1.1

—

Injuries to the hip and thigh

1.15

0.10

1.0

1.1

—

COPD differential diagnosis

101

1.09

0.10

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

135

0.92

0.09

1.0

1.1

—

Other and unspecified urticaria

1.09

0.09

1.0

1.1

—

Acute sinusitis

132

0.89

0.09

1.0

1.1

—

Anxiety disorders, excluding more controls

126

0.91

0.09

1.0

1.1

—

Benign neoplasms

147

1.07

0.09

1.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.06

0.09

1.4

1.0

—

5-aminosalicylic acid

1.04

0.09

1.0

—

Asthma, hospital admission 2, infections

121

0.89

0.09

1.1

1.0

—

Asthma-related infections

121

0.89

0.09

1.1

1.0

—

IBD patients in KELA-register

1.11

0.09

1.0

1.1

—

Other and unspecified iron deficiency

1.09

0.08

1.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

149

0.93

0.08

1.0

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

142

1.10

0.08

1.1

—

Fracture of foot, except ankle

1.05

0.08

1.0

1.1

—

Artificial joint operation, meniscal resection

0.80

0.08

1.4

1.1

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

0.83

0.08

1.0

—

Injuries to the neck

0.83

0.08

1.0

1.1

—

Nonsuppurative otitis media

0.88

0.08

1.0

1.1

—

Acute bronchitis

1.06

0.08

1.0

—

Inflammatory bowel disease

1.04

0.08

1.0

1.1

—

Excessive earwax

1.04

0.08

1.1

1.0

—

Other external causes of accidental injury

112

1.07

0.07

1.0

1.1

—

Pain, not elsewhere classified

0.81

0.07

1.0

1.1

—

Opioids

146

1.06

0.07

1.1

—

Anxiety (asthma-related co-morbidities)

141

1.08

0.07

1.1

—

Mood [affective] disorders

150

1.07

0.07

1.0

1.1

—

Excessive attrition of teeth

155

1.08

0.07

1.1

—

Asthma, excluding more controls

100

0.92

0.07

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.87

0.07

1.0

—

In situ neoplasms

0.86

0.07

1.0

1.1

—

Erosion of teeth , including avohilmo

0.82

0.07

1.0

1.1

—

Mood disorders

150

1.06

0.07

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

113

0.93

0.07

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.03

0.07

1.1

—

Migraine without aura and triptan purchases

0.86

0.06

1.0

1.1

—

Noninfective enteritis and colitis

0.85

0.06

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

149

1.08

0.06

1.0

1.1

—

129

1.06

0.06

1.0

1.1

—

Asthma

100

0.93

0.06

1.1

—

Other antidepressants

125

0.94

0.06

1.0

1.1

—

Other acute lower respiratory infections

0.87

0.06

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

104

0.87

0.06

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

132

1.06

0.06

1.0

1.1

—

COPD/asthma/ILD related infections

123

1.06

0.06

1.1

—

COPD/asthma related infections

123

1.06

0.06

1.1

—

Childhood asthma (age<16)

1.12

0.05

1.0

1.1

—

Childhood asthma (age<16), excluding more controls

1.12

0.05

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

119

0.91

0.05

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.07

0.05

1.1

—

109

0.91

0.05

1.1

1.0

—

Dorsalgia

139

0.95

0.04

1.1

—

Acute suppurative otitis media

121

0.92

0.04

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

106

0.95

0.04

1.0

1.1

—

Persons encountering health services in other circumstances

1.10

0.04

1.0

1.1

—

All anxiety disorders

147

1.06

0.04

1.1

—

Arthropathies

146

0.97

0.02

1.1

—

Intracranial injury

109

0.94

0.01

1.0

1.1

—

Bronchitis

151

1.03

0.01

1.0

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

133

1.04

0.01

1.1

—

Neurotic, stress-related and somatoform disorders

147

1.03

0.01

1.0

1.1

—

External causes of morbidity and mortality

102

1.03

0.00

1.0

1.1

—

Accidents

112

1.03

0.00

1.0

1.1

—

Falls/tendency to fall

147

1.02

0.00

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

131

0.98

0.00

1.0

1.1

—

Infections of the skin and subcutaneous tissue

127

1.01

0.00

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

161

0.97

0.00

1.1

—

Hypothyroidism, other/unspecified

149

1.01

0.00

1.0

1.1

—

Hypothyroidism, strict autoimmune

130

1.01

0.00

1.1

—

Anxiety disorders

147

1.03

0.00

1.0

1.1

—

Psychiatric diseases

111

0.99

0.00

1.0

1.1

—

Suppurative and unspecified otitis media

134

0.99

0.00

1.0

1.1

—

Sciatica+with lumbago

1.01

0.00

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

153

0.98

0.00

1.0

1.1

—

HSIL lesion of the cervix uteri

113

0.97

0.00

1.0

1.1

—

Excessive, frequent and irregular menstruation

1.04

0.00

1.0

1.1

—

First line medication for Crohn's disease

148

0.98

0.00

1.1

—

Dorsopathies

139

0.98

0.00

1.0

1.1

—

Any mental disorder

126

0.99

0.00

1.0

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

114

0.96

0.00

1.0

1.1

—

Transport accidents

109

0.99

0.00

1.2

1.1

—

Diseases of the musculoskeletal system and connective tissue

100

1.00

0.00

1.1

—

Asthma (only as main-diagnosis)

100

1.01

0.00

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

143

0.99

0.00

1.0

1.1

—

Endometriosis

0.97

0.00

1.0

1.1

—

Mood disorders, excluding more controls

126

0.98

0.00

1.0

1.1

—

Nonsuppurative otitis media, including avohilmo

117

0.96

0.00

1.0

1.1

—

Irregular menses

156

1.01

0.00

1.0

1.1

—

Asthma (only as main-diagnosis), excluding more controls

100

0.99

0.00

1.1

—

Codes for special purposes

131

0.98

0.00

1.0

1.1

—

Diseases of the respiratory system

0.98

0.00

1.1

—

Pain (limb, back, neck, head abdominally)

0.99

0.00

1.0

1.1

—

Complications of medical and surgical care

118

0.99

0.00

1.1

—

Asthma (mode)

100

1.00

0.00

1.1

—

Disorders of the thyroid gland

152

1.02

0.00

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

113

0.97

0.00

1.0

1.1

—

Hypothyroidism and >3 levothyroxin purchases

0.98

0.00

1.0

1.1

—

Hypothyroidism, levothyroxine purchases

0.98

0.00

1.0

1.1

—

Hypothyroidism (congenital or acquired)

0.98

0.00

1.0

1.1

—

Triptan medication for migraine, single purchase ok

134

1.01

0.00

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

134

1.01

0.00

1.1

—

Abdominal and pelvic pain

106

0.99

0.00

1.0

1.1

—

Impacted teeth

110

1.01

0.00

1.1

1.0

—

Triptan medication for migraine, min. 3 purchases

159

0.99

0.00

1.0

1.1

—

Other diseases of upper respiratory tract

126

0.99

0.00

1.0

1.1

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.0

1.0

—

Other disorders of bladder

0.00

0.0

1.0

—

Neuralgia and neuritis, unspecified

0.00

0.0

1.0

—

Golimumab

0.00

0.0

1.0

—

All dysplastic lesions of the vagina

0.00

0.0

1.0

—

Wide developmental disorders, excluding more controls

0.00

0.0

1.3

—

Sequelae of other external causes

0.00

0.0

1.0

—

Ingrowing nail

0.00

0.0

1.1

—

Other or unspecified ileus, impaction or obstruction

0.00

0.0

1.0

—

Varicella [chickenpox]

0.00

0.0

1.2

—

Continuous positive airway pressure

0.00

0.0

1.0

—

Congenital malformations of the nervous system

0.00

0.0

1.0

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.0

—

Periapical abscess

0.98

0.00

1.0

—

Other and unspecified iridocyclitis

0.00

0.0

1.0

—

Specific developmental disorder of motor function

0.00

0.0

1.2

—

Organic, including symptomatic, mental disorders

0.00

0.0

1.0

—

Osteoporosis

0.00

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

0.0

1.0

—

Scabies

0.00

0.0

1.1

—

Allergic asthma (mode)

0.95

0.00

1.1

—

Diseases of the myoneural junction and muscle

0.00

0.0

1.0

—

Secondary uncertain malignant neoplasm

0.00

0.0

1.0

—

Autism spe, excluding more controls

0.00

0.0

1.3

—

Nummular dermatitis

0.00

0.0

1.0

—

Adhesive capsulitis of shoulder

0.00

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

Benign neoplasm of mouth and pharynx

0.00

0.0

1.0

—

Irritable bowel syndrome

0.87

0.00

1.0

1.1

—

malignant neoplasm of female genital organs

0.00

0.0

1.0

—

Glomerulonephritis

0.00

0.0

1.0

—

Perioral dermatitis

0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

0.0

1.1

—

Benign neoplasm of meninges

0.00

0.0

1.0

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.0

1.0

—

Viral meningitis, including avohilmo

0.00

0.0

1.0

—

Other specified/unspecified bacterial intestinal infections

0.00

0.0

1.0

—

Nonspecific lymphadenitis

0.00

-0.00

0.0

1.0

—

Coxarthrosis, primary

0.00

-0.00

0.0

1.0

—

Seborrhoeic keratosis

0.00

-0.00

0.0

1.0

—

Epilepsy

0.92

-0.00

1.2

1.1

—

Autoimmune hepatitis, wide definition

0.00

-0.00

0.0

1.0

—

Reimbursement for rheumatic diseases

0.99

-0.00

1.2

1.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

-0.00

0.0

1.0

—

Other infectious diseases

0.00

-0.00

0.0

1.0

—

Malignant melanoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Hodgkin lymphoma, hilmo

0.00

-0.00

0.0

1.0

—

Disorders of orbit

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectum, anus and anal canal

0.00

-0.00

0.0

1.0

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

-0.00

0.0

1.0

—

Other functional intestinal disorders

0.92

-0.00

1.0

1.1

—

Chronic sinusitis

0.94

-0.00

1.0

1.1

—

Other disorders of Eustachian tube

0.00

-0.00

0.0

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.01

-0.00

1.1

—

Stenosis and insufficiency of lacrimal passages

0.00

-0.00

0.0

1.0

—

Achilles tendinitis

0.00

-0.00

0.0

1.0

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.0

—

Internal derangement of knee

0.90

-0.00

1.0

1.1

—

Other retinal disorders

1.00

-0.00

1.2

1.1

—

Hypermetropia

0.00

-0.00

0.0

1.1

—

Systemic connective tissue disorders

1.02

-0.00

1.2

1.1

—

Colectomy operation

0.00

-0.00

0.0

1.0

—

Anxious personality disorder

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.0

—

Other disorders of white blood cells

0.00

-0.00

0.0

1.0

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Non-ischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.2

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

1.0

—

Visual field defects

0.00

-0.00

0.0

1.0

—

Acute bronchiolitis

0.00

-0.00

0.0

1.1

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Dystonia

0.00

-0.00

0.0

1.0

—

Amblyopia ex anopsia

0.00

-0.00

0.0

1.1

—

Nontraumatic intracranial haemmorrhage

0.00

-0.00

0.0

1.0

—

Other diseases of arteries and capillaries

0.00

-0.00

0.0

1.0

—

Cardiomyopathy

0.00

-0.00

0.0

1.0

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.0

—

Eating disorder

0.89

-0.00

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

-0.00

0.0

1.0

—

Adrenocortical insufficiency

0.00

-0.00

0.0

1.0

—

Nontoxic single thyroid nodule

0.00

-0.00

0.0

1.0

—

Fracture of femur

0.00

-0.00

0.0

1.0

—

Other/unspecified dorsalgia

1.00

-0.00

1.0

1.1

—

Vertical strabismus

0.00

-0.00

0.0

1.0

—

Primary ovarian failure

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

-0.00

0.0

1.0

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Major coronary heart disease event excluding revascularizations

0.00

-0.00

0.0

1.0

—

Psoriatic arthropathies

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of trunk

0.00

-0.00

0.0

1.0

—

Sicca syndrome [Sjögren]

0.00

-0.00

0.0

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

-0.00

0.0

1.0

—

Abscess of Bartholin gland

0.00

-0.00

0.0

1.0

—

Suppurative otitis media, unspecified

0.00

-0.00

0.0

1.4

—

Chondrocostal junction syndrome [Tietze]

0.00

-0.00

0.0

1.2

—

Motor disorders

0.00

-0.00

0.0

1.2

—

Hyperhidrosis

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

1.0

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

1.0

—

Vitamin deficiency

0.00

-0.00

0.0

1.0

—

Whooping cough, including avohilmo

0.00

-0.00

0.0

1.0

—

Galactorrhea

0.00

-0.00

0.0

1.0

—

Use of glatiramer acetate

0.00

-0.00

0.0

1.0

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

1.0

—

Eating disorders

0.86

-0.00

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.01

-0.00

1.0

1.1

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.0

—

Malignant melanoma

0.00

-0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

1.0

—

Other diseases of biliary tract

0.00

-0.00

0.0

1.0

—

Post-traumatic stress disorder

0.98

-0.00

1.0

1.1

—

Autism

0.00

-0.00

0.0

1.1

—

Autism spe

0.00

-0.00

0.0

1.1

—

Other peripheral vertigo

0.00

-0.00

0.0

1.0

—

Lichen simplex chronicus and prurigo

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.1

—

Use of interferon beta-1a

0.00

-0.00

0.0

1.0

—

Sacrococcygeal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.0

—

Endometriosis ASRM stages 1,2

1.00

-0.00

1.0

1.1

—

SLE (Finngen)

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.99

-0.00

1.0

1.1

—

Vitamin deficiency, wide

0.00

-0.00

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

-0.00

0.0

1.0

—

Viral and other specified intestinal infections

0.91

-0.00

1.0

1.1

—

Invasive ventilation

0.00

-0.00

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

1.0

—

Insulin medication

0.92

-0.00

1.0

1.1

—

SLE, strict definition

0.00

-0.00

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.91

-0.00

1.0

1.1

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Generalized skin eruption due to drugs and medicaments

0.00

-0.00

0.0

1.0

—

Spasmodic torticollis

0.00

-0.00

0.0

1.0

—

Ehlers-Danlos syndrome, including avohilmo

0.00

-0.00

0.0

1.0

—

Primary gonarthrosis, bilateral

0.00

-0.00

0.0

1.0

—

Mandibular retrognathia AND surgery (BSSO)

0.00

-0.00

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

-0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system, including avohilmo

0.00

-0.00

0.0

1.1

—

Allergic asthma (mode), excluding more controls

0.94

-0.00

1.1

—

Postmenopausal atrophic vaginitis

0.00

-0.00

0.0

1.0

—

Other inflammatory liver diseases

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.1

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Chromosome analysis panel - Chorionic villus sample by G-banded

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS